chr5-13769148-T-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001369.3(DNAH5):​c.9721-12A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 1,612,898 control chromosomes in the GnomAD database, including 103,426 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 9292 hom., cov: 33)
Exomes 𝑓: 0.36 ( 94134 hom. )

Consequence

DNAH5
NM_001369.3 intron

Scores

2
Splicing: ADA: 0.00001179
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.82
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 5-13769148-T-A is Benign according to our data. Variant chr5-13769148-T-A is described in ClinVar as [Benign]. Clinvar id is 167003.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-13769148-T-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH5NM_001369.3 linkc.9721-12A>T intron_variant Intron 57 of 78 ENST00000265104.5 NP_001360.1 Q8TE73

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH5ENST00000265104.5 linkc.9721-12A>T intron_variant Intron 57 of 78 1 NM_001369.3 ENSP00000265104.4 Q8TE73
DNAH5ENST00000681290.1 linkc.9676-12A>T intron_variant Intron 57 of 78 ENSP00000505288.1 A0A7P0Z455
DNAH5ENST00000504001.3 linkn.433-12A>T intron_variant Intron 3 of 4 5

Frequencies

GnomAD3 genomes
AF:
0.349
AC:
52965
AN:
151936
Hom.:
9288
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.332
Gnomad AMI
AF:
0.461
Gnomad AMR
AF:
0.356
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.331
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.326
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.362
GnomAD3 exomes
AF:
0.339
AC:
85137
AN:
250844
Hom.:
14784
AF XY:
0.338
AC XY:
45788
AN XY:
135554
show subpopulations
Gnomad AFR exome
AF:
0.330
Gnomad AMR exome
AF:
0.328
Gnomad ASJ exome
AF:
0.375
Gnomad EAS exome
AF:
0.322
Gnomad SAS exome
AF:
0.247
Gnomad FIN exome
AF:
0.336
Gnomad NFE exome
AF:
0.368
Gnomad OTH exome
AF:
0.372
GnomAD4 exome
AF:
0.357
AC:
520957
AN:
1460844
Hom.:
94134
Cov.:
35
AF XY:
0.353
AC XY:
256535
AN XY:
726840
show subpopulations
Gnomad4 AFR exome
AF:
0.339
Gnomad4 AMR exome
AF:
0.333
Gnomad4 ASJ exome
AF:
0.372
Gnomad4 EAS exome
AF:
0.323
Gnomad4 SAS exome
AF:
0.246
Gnomad4 FIN exome
AF:
0.338
Gnomad4 NFE exome
AF:
0.368
Gnomad4 OTH exome
AF:
0.364
GnomAD4 genome
AF:
0.348
AC:
52985
AN:
152054
Hom.:
9292
Cov.:
33
AF XY:
0.347
AC XY:
25745
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.332
Gnomad4 AMR
AF:
0.356
Gnomad4 ASJ
AF:
0.361
Gnomad4 EAS
AF:
0.332
Gnomad4 SAS
AF:
0.238
Gnomad4 FIN
AF:
0.326
Gnomad4 NFE
AF:
0.367
Gnomad4 OTH
AF:
0.360
Alfa
AF:
0.276
Hom.:
1023
Bravo
AF:
0.354
Asia WGS
AF:
0.292
AC:
1015
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

9721-12A>T in intron 57 of DNAH5: This variant is not expected to have clinical significance because it has been identified in 37.8% (3248/8600) of European Ame rican chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs12655133). -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 18, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Primary ciliary dyskinesia 3 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 15, 2021
Pars Genome Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.056
DANN
Benign
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000012
dbscSNV1_RF
Benign
0.044
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12655133; hg19: chr5-13769257; COSMIC: COSV54227247; API